NASDAQ · Unclassified100% Authentic Upstream Feed (MR-007)

Regeneron Pharmaceuticals Inc (REGN)

Real-time institutional stock price, dual quantitative model evaluation (4-Factor Quant Rank + 6-Factor Fundamental Composite), valuation multiples, and forensic accounting audit.

Live Authentic Market Price
$940.50
+$24.44 (+2.67%)
Vol: 468,670
Market Capitalization$97.34B
P/E Multiple (TTM)—
52-Week Range$591.52 – $991.73
Beta / Volatility0.10
Model A · Equal-Weight 25%

4-Factor Quant Rank

#971
Percentile Score:57.7 / 100
Valuation Percentile:63.7
Growth Percentile:54.4
Business Quality Percentile:77.5
Momentum Percentile:35.2
Cross-sectional universe comparison across 2,714 U.S. equities (Official v2.1).
Model B · Fundamental Pillars

6-Factor Fundamental Rating

Evaluation Pending
Fundamental Score:
Pending
Valuation:—
Growth:—
Profitability:—
Financial Health:—
EPS Revisions:—
Dividend Quality:—
Absolute balance sheet health and SEC Edgar filing verification.

Source-Backed Financial Highlights

SEC EDGAR & Market Data Lineage
Revenue (TTM)—
Diluted EPS—
Forward P/E—
Price to Sales—
Operating Margin—
Net Margin—

Institutional Peer Comparison Cohort

Direct sector comparables for Regeneron Pharmaceuticals Inc in Unclassified

4-Factor Quant Benchmarks
VRTXVRTX Common Stock
Compare→
GILDGILD Common Stock
Compare→
BIIBBIIB Common Stock
Compare→
AMGNAMGN Common Stock
Compare→